Xitian Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xitian Hu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Shuo Wang
Department of Cardiology Shijiazhuang People's Hospital Shijiazhuang Hebei China
2 shared publicationsJingjie Dong
Department of Cardiology Shijiazhuang People's Hospital Shijiazhuang Hebei China
1 shared publicationLei Xu
Department of Cardiology Shijiazhuang People's Hospital Shijiazhuang Hebei China
1 shared publicationLiu Li
Department of Three Cardiac, the First Hospital of Hebei Medical University
1 shared publication- Liu Li
Department of Cardiovascular Medicine, Hebei Medical University First Hospital, Shijiazhuang, China
1 shared publication Rubing Wu
Department of Cardiology Shijiazhuang People's Hospital Shijiazhuang Hebei China
1 shared publication
Latest Publications
- 23 November 2021
- Published by Hindawi Limited in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 16 (2) , 177-187
Exosomes derived from miR‐129‐5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction
Myocardial infraction (MI) is a severe disease with great mortality. Mesenchymal stem cells-derived exosomes display protection against MI. MicroRNA-129-5p was reported to exert anti-inflammation activity by targeting high mobility group box 1 (HMGB1). In the present study, the effects of MSCs derived exosomes overexpressing miR-129-5p on MI were evaluated. Bone marrow mesenchymal stem cells (BMSCs) were transfected with miR-129-5p for exosomes isolation. Myocardial infraction mice model was established and administrated exosomes overexpressing miR-129-5p. The cardiac function, expression of HMGB1, inflammatory cytokines, apoptosis and fibrosis in heart tissues were measured. miR-129-5p inhibited HMGB1 expression in BMSCs. Myocardial infraction mice treated with exosomes overexpressing miR-129-5p had enhanced cardiac function and decreased expression of HMGB1 and production of inflammatory cytokines. Exosomes overexpressing miR-129-5p further prevented apoptosis and fibrosis. Exosome-mediated transfer of miR-129-5p suppressed inflammation in MI mice by targeting HMGB1.
- 23 November 2021
- Published by Hindawi Limited in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 16 (2) , 177-187
Exosomes derived from miR‐129‐5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction
Myocardial infraction (MI) is a severe disease with great mortality. Mesenchymal stem cells-derived exosomes display protection against MI. MicroRNA-129-5p was reported to exert anti-inflammation activity by targeting high mobility group box 1 (HMGB1). In the present study, the effects of MSCs derived exosomes overexpressing miR-129-5p on MI were evaluated. Bone marrow mesenchymal stem cells (BMSCs) were transfected with miR-129-5p for exosomes isolation. Myocardial infraction mice model was established and administrated exosomes overexpressing miR-129-5p. The cardiac function, expression of HMGB1, inflammatory cytokines, apoptosis and fibrosis in heart tissues were measured. miR-129-5p inhibited HMGB1 expression in BMSCs. Myocardial infraction mice treated with exosomes overexpressing miR-129-5p had enhanced cardiac function and decreased expression of HMGB1 and production of inflammatory cytokines. Exosomes overexpressing miR-129-5p further prevented apoptosis and fibrosis. Exosome-mediated transfer of miR-129-5p suppressed inflammation in MI mice by targeting HMGB1.
- 1 June 2020
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 15 (6) , 1749-1759
Mir-19A/19B-Loaded Exosomes in Combination with Mesenchymal Stem Cell Transplantation in A Preclinical Model of Myocardial Infarction
Aim: We aimed to investigate the protection of exogenous miR-19a/19b with bone marrow-derived mesenchymal stem cell (BM-MSC) transplantation on cardiac function and inhibition of fibrosis in myocar...
- 1 June 2020
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 15 (6) , 1749-1759
Mir-19A/19B-Loaded Exosomes in Combination with Mesenchymal Stem Cell Transplantation in A Preclinical Model of Myocardial Infarction
Aim: We aimed to investigate the protection of exogenous miR-19a/19b with bone marrow-derived mesenchymal stem cell (BM-MSC) transplantation on cardiac function and inhibition of fibrosis in myocar...